These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. The significance of differences in fatty acid metabolism between obese and non-obese patients with non-alcoholic fatty liver disease. Nakamuta M; Kohjima M; Higuchi N; Kato M; Kotoh K; Yoshimoto T; Yada M; Yada R; Takemoto R; Fukuizumi K; Harada N; Taketomi A; Maehara Y; Nakashima M; Enjoji M Int J Mol Med; 2008 Nov; 22(5):663-7. PubMed ID: 18949388 [TBL] [Abstract][Full Text] [Related]
25. Increased hepatic and circulating interleukin-6 levels in human nonalcoholic steatohepatitis. Wieckowska A; Papouchado BG; Li Z; Lopez R; Zein NN; Feldstein AE Am J Gastroenterol; 2008 Jun; 103(6):1372-9. PubMed ID: 18510618 [TBL] [Abstract][Full Text] [Related]
27. Fibrosis in genotype 3 chronic hepatitis C and nonalcoholic fatty liver disease: Role of insulin resistance and hepatic steatosis. Bugianesi E; Marchesini G; Gentilcore E; Cua IH; Vanni E; Rizzetto M; George J Hepatology; 2006 Dec; 44(6):1648-55. PubMed ID: 17133473 [TBL] [Abstract][Full Text] [Related]
28. [Non-alcoholic fatty liver disease--new view]. Raszeja-Wyszomirska J; Lawniczak M; Marlicz W; Miezyńska-Kurtycz J; Milkiewicz P Pol Merkur Lekarski; 2008 Jun; 24(144):568-71. PubMed ID: 18702346 [TBL] [Abstract][Full Text] [Related]
29. Nonalcoholic fatty liver disease: an increasingly common cause of liver disease among HIV-infected persons? Crum-Cianflone NF AIDS Read; 2007 Oct; 17(10):513-8. PubMed ID: 17990373 [TBL] [Abstract][Full Text] [Related]
30. Associations between plasma adiponectin concentrations and liver histology in patients with nonalcoholic fatty liver disease. Targher G; Bertolini L; Rodella S; Zoppini G; Scala L; Zenari L; Falezza G Clin Endocrinol (Oxf); 2006 Jun; 64(6):679-83. PubMed ID: 16712671 [TBL] [Abstract][Full Text] [Related]
31. Association of cardiorespiratory fitness, body mass index, and waist circumference to nonalcoholic fatty liver disease. Church TS; Kuk JL; Ross R; Priest EL; Biltoft E; Blair SN Gastroenterology; 2006 Jun; 130(7):2023-30. PubMed ID: 16762625 [TBL] [Abstract][Full Text] [Related]
32. NAFLD in children: a prospective clinical-pathological study and effect of lifestyle advice. Nobili V; Marcellini M; Devito R; Ciampalini P; Piemonte F; Comparcola D; Sartorelli MR; Angulo P Hepatology; 2006 Aug; 44(2):458-65. PubMed ID: 16871574 [TBL] [Abstract][Full Text] [Related]
33. Risk factors associated with nonalcoholic fatty liver disease and its relationship with the hepatic histological changes. Rodríguez-Hernández H; Gonzalez JL; Márquez-Ramirez MD; Flores-Hernandez M; Rodríguez-Morán M; Guerrero-Romero F Eur J Gastroenterol Hepatol; 2008 May; 20(5):399-403. PubMed ID: 18403941 [TBL] [Abstract][Full Text] [Related]
35. Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease. Harrison SA; Oliver D; Arnold HL; Gogia S; Neuschwander-Tetri BA Gut; 2008 Oct; 57(10):1441-7. PubMed ID: 18390575 [TBL] [Abstract][Full Text] [Related]
36. Pathology of nonalcoholic fatty liver disease. Yeh MM; Brunt EM Am J Clin Pathol; 2007 Nov; 128(5):837-47. PubMed ID: 17951208 [TBL] [Abstract][Full Text] [Related]
37. Nonalcoholic fatty liver disease in HIV-infected patients referred to a metabolic clinic: prevalence, characteristics, and predictors. Guaraldi G; Squillace N; Stentarelli C; Orlando G; D'Amico R; Ligabue G; Fiocchi F; Zona S; Loria P; Esposito R; Palella F Clin Infect Dis; 2008 Jul; 47(2):250-7. PubMed ID: 18532884 [TBL] [Abstract][Full Text] [Related]
39. Should nonalcoholic fatty liver disease be included in the definition of metabolic syndrome? A cross-sectional comparison with Adult Treatment Panel III criteria in nonobese nondiabetic subjects. Musso G; Gambino R; Bo S; Uberti B; Biroli G; Pagano G; Cassader M Diabetes Care; 2008 Mar; 31(3):562-8. PubMed ID: 18056890 [TBL] [Abstract][Full Text] [Related]